Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midostaurin + Decitabine in Unfit AML/MDS
NCT04097470Phase 2Active, not recruiting
- Sponsor
- HOVON
- Start
- Dec 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of midostaurin in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by HOVON. Started Dec 2019; status: active, not recruiting.
02
Drugs
midostaurin
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT04097470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04097470.